BDBM627408 (S,Z)-1-(4-(1-Bromo-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 67

SMILES COc1cc(\C(Br)=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F

InChI Key InChIKey=KRZPEHDSXLASQW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 627408   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Guangzhou Maxinovel Pharmaceuticals

US Patent
LigandPNGBDBM627408((S,Z)-1-(4-(1-Bromo-2-(2-methyl-[1,1'-biphenyl]-3-...)
Affinity DataIC50: 12.8nMAssay Description:Homogeneous time-resolved fluorescence (HTRF) binding assay was used to determine the binding ability of the compound of the present disclosure to PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/1/2023
Entry Details
Go to US Patent